Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion

scientific article

Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/TME.12323
P698PubMed publication ID27238953

P50authorBettina SchenkQ60649509
P2093author name stringD Fries
C Fenger-Eriksen
H Munk-Andersen
O H Larsen
P2860cites workThe effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopeniaQ28235488
Hemostasis during normal pregnancy and puerperiumQ33347620
The effect of fibrinogen concentrate on thrombocytopeniaQ33375024
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.Q33375450
Reactions Induced by Platelet TransfusionsQ33395008
Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopeniaQ33415059
Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patientsQ33416666
Platelet transfusions: Impact on hemostasis, thrombosis, inflammation and clinical outcomesQ34708937
Fibrinogen as a hemostatic agentQ37998405
Platelet storage and transfusions: new concerns associated with an old therapyQ38015853
Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trialQ44761345
Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial.Q50513481
The German Haemovigilance System--reports of serious adverse transfusion reactions between 1997 and 2007.Q50598282
P433issue4
P921main subjectplatelet transfusionQ23925170
P304page(s)291-296
P577publication date2016-05-30
P1433published inTransfusion MedicineQ15758505
P1476titleFibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion
P478volume26